Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1994 1
1995 2
1996 2
1997 1
1998 2
2000 3
2001 3
2004 2
2005 5
2006 3
2007 2
2008 7
2009 6
2010 15
2011 11
2012 11
2013 11
2014 15
2015 29
2016 26
2017 15
2018 14
2019 9
2020 12
2021 12
2022 30
2023 22
2024 14
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

254 results

Results by year

Filters applied: . Clear all
Page 1
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial.
Fangusaro J, Onar-Thomas A, Young Poussaint T, Wu S, Ligon AH, Lindeman N, Banerjee A, Packer RJ, Kilburn LB, Goldman S, Pollack IF, Qaddoumi I, Jakacki RI, Fisher PG, Dhall G, Baxter P, Kreissman SG, Stewart CF, Jones DTW, Pfister SM, Vezina G, Stern JS, Panigrahy A, Patay Z, Tamrazi B, Jones JY, Haque SS, Enterline DS, Cha S, Fisher MJ, Doyle LA, Smith M, Dunkel IJ, Fouladi M. Fangusaro J, et al. Among authors: panigrahy a. Lancet Oncol. 2019 Jul;20(7):1011-1022. doi: 10.1016/S1470-2045(19)30277-3. Epub 2019 May 28. Lancet Oncol. 2019. PMID: 31151904 Free PMC article. Clinical Trial.
Loss of MAT2A compromises methionine metabolism and represents a vulnerability in H3K27M mutant glioma by modulating the epigenome.
Golbourn BJ, Halbert ME, Halligan K, Varadharajan S, Krug B, Mbah NE, Kabir N, Stanton AJ, Locke AL, Casillo SM, Zhao Y, Sanders LM, Cheney A, Mullett SJ, Chen A, Wassell M, Andren A, Perez J, Jane EP, Premkumar DRD, Koncar RF, Mirhadi S, McCarl LH, Chang YF, Wu YL, Gatesman TA, Cruz AF, Zapotocky M, Hu B, Kohanbash G, Wang X, Vartanian A, Moran MF, Lieberman F, Amankulor NM, Wendell SG, Vaske OM, Panigrahy A, Felker J, Bertrand KC, Kleinman CL, Rich JN, Friedlander RM, Broniscer A, Lyssiotis C, Jabado N, Pollack IF, Mack SC, Agnihotri S. Golbourn BJ, et al. Among authors: panigrahy a. Nat Cancer. 2022 May;3(5):629-648. doi: 10.1038/s43018-022-00348-3. Epub 2022 Apr 14. Nat Cancer. 2022. PMID: 35422502 Free PMC article.
Pediatric brain tumors.
Poussaint TY, Panigrahy A, Huisman TA. Poussaint TY, et al. Among authors: panigrahy a. Pediatr Radiol. 2015 Sep;45 Suppl 3:S443-53. doi: 10.1007/s00247-015-3326-8. Epub 2015 Sep 7. Pediatr Radiol. 2015. PMID: 26346150 Review.
Phase II Trial of Response-Based Radiation Therapy for Patients With Localized CNS Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study.
Fangusaro J, Wu S, MacDonald S, Murphy E, Shaw D, Bartels U, Khatua S, Souweidane M, Lu HM, Morris D, Panigrahy A, Onar-Thomas A, Fouladi M, Gajjar A, Dhall G. Fangusaro J, et al. Among authors: panigrahy a. J Clin Oncol. 2019 Dec 1;37(34):3283-3290. doi: 10.1200/JCO.19.00701. Epub 2019 Sep 23. J Clin Oncol. 2019. PMID: 31545689 Free PMC article. Clinical Trial.
Reply.
Panigrahy A, Lo CW. Panigrahy A, et al. J Pediatr. 2017 Jun;185:253-254. doi: 10.1016/j.jpeds.2017.02.022. Epub 2017 Mar 7. J Pediatr. 2017. PMID: 28283257 No abstract available.
Arterial Spin Labeling in Pediatric Neuroimaging.
Narayanan S, Schmithorst V, Panigrahy A. Narayanan S, et al. Among authors: panigrahy a. Semin Pediatr Neurol. 2020 Apr;33:100799. doi: 10.1016/j.spen.2020.100799. Epub 2020 Jan 20. Semin Pediatr Neurol. 2020. PMID: 32331614 Review.
254 results